NCT04776850 Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies Status WITHDRAWN Phase EARLY_PHASE1
NCT04747080 The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04701528 Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients Status COMPLETED Phase PHASE2
NCT04669210 PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT Status COMPLETED Phase PHASE2
NCT04657562 The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma Status UNKNOWN Phase N/A
NCT04645667 Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT) Status COMPLETED Phase N/A
NCT04629248 A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04530487 Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults Status TERMINATED Phase PHASE2
NCT04521946 Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer Status WITHDRAWN Phase PHASE1
NCT04498741 Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04469842 Early Use of Long-acting Tacrolimus in Lung Transplant Recipients Status RECRUITING Phase EARLY_PHASE1
NCT04444817 Evaluation of the Impact of Tacrolimus-based Immunosuppression on Heidelberg Liver Transplant Cohort (HDTACRO): Study Protocol for an Investigator Initiated, Non-interventional Prospective Study Status UNKNOWN Phase N/A
NCT04403321 Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients Status COMPLETED Phase PHASE2
NCT04384692 Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04370301 Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis Status RECRUITING Phase PHASE2
NCT04360031 The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation Status UNKNOWN Phase N/A
NCT04341038 Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury Status UNKNOWN Phase PHASE3
NCT04339101 Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation Status COMPLETED Phase PHASE2